Infectious disease
There have been some concerns over the accuracy of COVID-19 rapid antigen tests—the clinical diagnostic tests that evaluate for active infections by testing for the presence of the virus’s antigens.
A recent study found that Vitamin D deficiency may be associated with an increased COVID-19 risk.
Despite the greenlight from the U.S. Food and Drug Administration as an emergency treatment, there are some questions about how effective the treatment will actually prove to be due to labeling limitations.
A group of Researchers in St. Louis published the results of a clinical trial evaluating antidepressant fluvoxamine, for early treatment for COVID-19.
Integrating digital tools for manufacturing process development, control and data analytics brings data together in ways that enhance visibility system-wide.
Vaxart announced new data from its Hamster Challenge Study today, showing that its oral COVID-19 vaccine candidate can potentially reduce viral load and induce a significant immune response.
The company said they needed 53 patients in the study to be diagnosed with COVID-19, and the trial hit that figure yesterday.
AstraZeneca reported that the CALAVI Phase II trials of Calquence (acalabrutinib) in hospitalized patients with respiratory symptoms of COVID-19 failed to meet the trials’ primary efficacy endpoint.
After months of urging the public to wear masks and facial coverings to help stop infected people from spreading COVID-19, the Centers for Disease Control and Prevention now states in newly released guidance that masks also protected the mask wearer from being infected.
Even if the vaccine is given the greenlight by regulatory agencies, it will still take some time for the vaccine to be distributed to a wide swath of the population.
PRESS RELEASES